Synergy Pharmaceuticals: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Synergy Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -�SGYP

(marketscreener.com) NEW YORK, March 21, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Synergy Pharmaceutical, Inc. ("Synergy" or the "Company") (NASDAQ: SGYP) against certain of the Company's current and former officers and directors. The class action, filed in...http://www.marketscreener.com/news/Pomerantz-Law-Firm-Reminds-Shareholders-with-Losses-on-their-Investment-in-Synergy-Pharmaceuticals--28209669/?utm_medium=RSS&utm_content=20190321